Format

Send to

Choose Destination
J Clin Invest. 2006 Oct;116(10):2585-7.

Imaging tumor angiogenesis.

Author information

1
Genentech Inc., South San Francisco, California 94080, USA.

Abstract

Since the discovery of vascular-specific growth factors with angiogenic activity, there has been a significant effort to develop cancer drugs that restrict tumorigenesis by targeting the blood supply. In this issue of the JCI, Mancuso et al. use mouse models to better understand the plasticity of the tumor vasculature in the face of antiangiogenic therapy (see the related article beginning on page 2610). They describe a rapid regrowth of the tumor vasculature following withdrawal of VEGFR inhibitors, emphasizing the importance of fully understanding the function of these and similar treatments used in the clinic at the cellular and molecular level.

PMID:
17016553
PMCID:
PMC1578634
DOI:
10.1172/JCI30058
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center